Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 1 2014

Topics - Drug Discovery

Refine by Date:
From: To:
Published September 29, 2014
Expands gene-editing capabilities Read More »
Published September 25, 2014
Sees growth in small molecule discovery technology Read More »
Published September 22, 2014
Silarus Therapeutics and Thyritope Biosciences will receive $10M in financing and R&D support Read More »
Published September 15, 2014
Evotec to provide screening of compound libraries in multiple assay formats Read More »
Published September 8, 2014
Therapeutic antibodies target autoimmune disease Read More »
Published August 19, 2014
Evotec to provide compound management services to support malaria research Read More »
Published July 15, 2014
To employ Fluofarma discovery and translational services Read More »
Published July 8, 2014
Expands Evotec's drug discovery platform Read More »
Published July 3, 2014
To establish library of more than 200,000 compounds Read More »
Published June 23, 2014
Transitions compound into preclinical development Read More »
Published June 11, 2014
X-Chem to apply discovery engine to identify novel leads Read More »
Published June 5, 2014
Will share R&D rights to gene editing technology Read More »
Published June 4, 2014
Shire invests $20.4 million in arGEN-X Read More »
Published June 4, 2014
Will continue to explore new approaches in metabolic disease Read More »
Published May 15, 2014
Adds high-throughput screening, drug combination sciences and bioinformatics expertise Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On